EDAP TMS S.A. (FOCL)
NASDAQ: FOCL · Real-Time Price · USD
5.18
-0.02 (-0.38%)
At close: Jul 2, 2026, 4:00 PM EDT
5.19
+0.01 (0.19%)
After-hours: Jul 2, 2026, 4:04 PM EDT
EDAP TMS Revenue
EDAP TMS had revenue of $17.81M in the quarter ending March 31, 2026, with 24.85% growth. This brings the company's revenue in the last twelve months to $75.23M, up 12.37% year-over-year. In the year 2025, EDAP TMS had annual revenue of $70.53M with 1.63% growth.
Revenue (ttm)
$75.23M
Revenue Growth
+12.37%
P/S Ratio
2.62
Revenue / Employee
$256,304
Employees
289
Market Cap
194.16M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 70.53M | 1.13M | 1.63% |
| Dec 31, 2024 | 69.40M | 2.60M | 3.89% |
| Dec 31, 2023 | 66.80M | 7.68M | 13.00% |
| Dec 31, 2022 | 59.11M | 9.00M | 17.97% |
| Dec 31, 2021 | 50.11M | -630.80K | -1.24% |
| Dec 31, 2020 | 50.74M | 348.30K | 0.69% |
| Dec 31, 2019 | 50.39M | 5.36M | 11.91% |
| Dec 31, 2018 | 45.03M | 2.14M | 4.98% |
| Dec 31, 2017 | 42.89M | 5.42M | 14.47% |
| Dec 31, 2016 | 37.47M | 2.45M | 6.99% |
| Dec 31, 2015 | 35.02M | 2.61M | 8.06% |
| Dec 31, 2014 | 32.41M | -705.60K | -2.13% |
| Dec 31, 2013 | 33.11M | -1.27M | -3.69% |
| Dec 31, 2012 | 34.38M | 5.52M | 19.14% |
| Dec 31, 2011 | 28.86M | -2.84M | -8.96% |
| Dec 31, 2010 | 31.70M | -3.98M | -11.17% |
| Dec 31, 2009 | 35.68M | 3.55M | 11.06% |
| Dec 31, 2008 | 32.13M | -508.40K | -1.56% |
| Dec 31, 2007 | 32.64M | 5.97M | 22.39% |
| Dec 31, 2006 | 26.66M | 2.08M | 8.44% |
| Dec 31, 2005 | 24.59M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionFOCL News
- 4 days ago - FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients - GlobeNewsWire
- 12 days ago - FocalTherics initiated with a Buy at Lucid Capital - TheFly
- 18 days ago - FocalTherics™ Expands Access to Focal One® Robotic HIFU for Veterans with Prostate Cancer through Agreement with MellingMedical - GlobeNewsWire
- 4 weeks ago - EDAP TMS Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - EDAP TMS Transcript: Investor Day 2026 - Transcripts
- 4 weeks ago - EDAP TMS Slides: FY 2026 - Filings
- 5 weeks ago - EDAP Announces Corporate Name Change to FocalTherics™ to Reflect Exclusive Focus on High-Growth Robotic Focal Therapy - GlobeNewsWire
- 6 weeks ago - EDAP | Focal One to Present at Jefferies 2026 Global Healthcare Conference - GlobeNewsWire